TG Therapeutics | TGTX - Ativo Circulante





Ativo Circulante Alterar Data
AbbVie USD 33.53B 4.47B 2026-03
Alaunos Therapeutics USD 1.99M 697K 2025-12
Amgen USD 31.48B 2.42B 2026-03
Ardelyx USD 381.87M 447K 2026-03
Arrowhead Research USD 1.84B 665.36M 2026-03
Bayer EUR 35.3B 2.39B 2026-03
Biogen USD 9.19B 216.3M 2026-03
Corcept Therapeutics USD 426.03M 59.43M 2026-03
Curis USD 6.92M 7.5M 2025-12
Gilead Sciences USD 18.64B 1.25B 2026-03
Infinity Pharmaceuticals USD 19.91M 8.46M 2023-06
J&J USD 59.17B 3.55B 2026-03
Karyopharm Therapeutics USD 103.15M 13.4M 2025-12
Novartis USD 26.61B 3.85B 2026-03
Novavax USD 850.82M 127.46M 2026-03
PTC Therapeutics USD 2.25B 19.94M 2026-03
Puma Biotechnology USD 143.58M 7M 2025-09
Regeneron Pharmaceuticals USD 18.21B 187.3M 2026-03
Roche Holding CHF 38.73B 3.03B 2025-12
TG Therapeutics USD 1.09B 456.2M 2026-03
Verastem USD 223.41M 69.36M 2025-12
Vertex Pharmaceuticals USD 11.73B 529.3M 2026-03